au.\*:("KLOTZ U")
Results 1 to 25 of 215
Selection :
BIOAVAILABILITY OF A SLOW-RELEASE PREPARATION OF VALPROIC ACID UNDER STEADY-STATE CONDITIONSKLOTZ U.1982; INT. J. CLIN. PHARMACOL. THER. TOXICOL.; DEU; DA. 1982; VOL. 20; NO 1; PP. 24-26; BIBL. 12 REF.Article
EFFECT OF AGE ON LEVELS OF DIAZEPAM IN PLASMA AND BRAIN OF RATSKLOTZ U.1979; ARCH. (NAUNYN-SCHMIEDEBERG'S) PHARMACOL.; DEU; DA. 1979; VOL. 307; NO 2; PP. 167-169; BIBL. 15 REF.Article
KLINISCHE PHARMAKOKINETIK VON DIAZEPAM UND SEINEN BIOLOGISCH AKTIVEN METABOLITEN = PHARMACOCINETIQUE DU DIAZEPAM ET DE SES METABOLITES BIOLOGIQUEMENT ACTIFSKLOTZ U.1978; KLIN. WSCHR.; DEU; DA. 1978; VOL. 56; NO 18; PP. 895-904; ABS. ENG; BIBL. 46 REF.Article
PHARMACOKINETIC STUDIES WITH VALPROIC ACID IN MAN.KLOTZ U.1977; ARZNEIMITTEL-FORSCH.; DTSCH.; DA. 1977; VOL. 27; NO 5; PP. 1085-1088; ABS. ALLEM.; BIBL. 13 REF.Article
THE BIOAVAILABILITY OF ALPHA -ACETYLDIGOXIN FROM CARD-HYDERGINAA FIXED COMBINATION OF HYDERGINE AND ACETYLDIGOXIN.KLOTZ U.1978; INTERNATION. J. CLIN. PHARMACOL. BIOPHARM.; GERM.; DA. 1978; VOL. 16; NO 3; PP. 116-118; BIBL. 6 REF.Article
WICHTIGE FAKTOREN, DIE BEIM MENSCHEN DIE VERTEILUNG UND ELIMINATION VON DIAZEPAM BEEINFLUSSEN. = FACTEURS IMPORTANTS INFLUENCANT CHEZ L'HOMME LA DISTRIBUTION ET L'ELIMINATION DU DIAZEPAMKLOTZ U.1977; FORTSCHR. D. MED.; DTSCH.; DA. 1977; VOL. 95; NO 32; PP. 1958-1964 (5P.); ABS. ANGL.; BIBL. 17 REF.Article
DETERMINATION OF BROMAZEPAM BY GAS-LIQUID CHROMATOGRAPHY AND ITS APPLICATION FOR PHARMACOKINETIC STUDIES IN MANKLOTZ U.1981; J. CHROMATOGR.; ISSN 0021-9673; NLD; DA. 1981; VOL. 222; NO 3; PP. 501-506; BIBL. 9 REF.Article
ANTIKONVULSIVA-PLASMASPREGEL. ERFAHRUNGEN MIT ROUTINEMAESSIGEN PLASMASPIEGE-BESTIMMUNGEN VON 6 VERSCHIEDENEN ANTIKONVULSIVA. = TAUX PLASMATIQUES D'ANTICONVULSIVANTS. EXPERIENCE DU DOSAGE DE ROUTINE DES TAUX PLASMATIQUES DE 6 ANTICONVULSIVANTS DIFFERENTSKLOTZ U.1978; FORTSCHR. D. MED.; DTSCH.; DA. 1978; VOL. 96; NO 1; PP. 9-13; BIBL. 7 REF.Article
INFLUENCE OF LIVER DISEASE ON THE ELIMINATION OF DRUGS.KLOTZ U.1976; EUROP. J. DRUG METABOL. PHARMACOKINET.; FR.; DA. 1976; VOL. 1; NO 3; PP. 129-140; BIBL. 2 P.Article
PATHOPHYSIOLOGICAL AND DISEASE-INDUCED CHANGES IN DRUG DISTRIBUTION VOLUME: PHARMACOKINETIC IMPLICATIONSKLOTZ U.1976; CLIN. PHARMACOKINET.; NETHERL.; DA. 1976; VOL. 1; NO 3; PP. 204-218; BIBL. 3 P. 1/2Article
Paracetamol (Acetaminophen) ― a Popular and Widely Used onopioid AnalgesicKLOTZ, U.Arzneimittel-Forschung. 2012, Vol 62, Num 8, pp 355-359, issn 0004-4172, 5 p.Article
Performance of a new automated substrate-labeled fluorescence immunoassay system evaluated by comparative therapeutic monitoring of five drugsKLOTZ, U.Therapeutic drug monitoring. 1984, Vol 6, Num 3, pp 355-359, issn 0163-4356Article
PHYSIOLOGIC AND TEMPORAL VARIATION IN HEPATIC ELIMINATION OF MIDAZOLAMKLOTZ U; ZIEGLER G.1982; CLIN. PHARMACOL. THER.; ISSN 0009-9236; USA; DA. 1982; VOL. 32; NO 1; PP. 107-112; BIBL. 27 REF.Article
VALPROIC ACID IN CHILDHOOD EPULEPSY: ANTICONVULSIVE EFFICACY IN RELATION TO ITS PLASMA LEVELSKLOTZ U; SCHWEIZER C.1980; INT. J. CLIN. PHARMACOL. THER. TOXICOL.; DEU; DA. 1980; VOL. 18; NO 10; PP. 461-465; BIBL. 16 REF.Article
PHYSICAL EXERCISE AND DISPOSITION OF DIAZEPAM.KLOTZ U; LUCKE C.1978; BRIT. J. CLIN. PHARMACOL.; G.B.; DA. 1978; VOL. 5; NO 4; PP. 349-350; BIBL. 9 REF.Article
AFFINITY CHROMATOGRAPHIC ISOLATION OF THE PERIPLASMIC MALTOSE BINDING PROTEIN OF ESCHERICHIA COLIFERENCI T; KLOTZ U.1978; F.E.B.S. LETTERS; NLD; DA. 1978; VOL. 94; NO 2; PP. 213-217; BIBL. 16 REF.Article
Comparison of cyclosporine blood levels measured by radioimmunoassay and TDx assay using monoclonal antibodiesKLOTZ, U.Therapeutic drug monitoring. 1991, Vol 13, Num 5, pp 461-463, issn 0163-4356Article
Clinical pharmacokinetics of sulphasalazine, its metabolites and other prodrugs of 5-aminosalicylic acidKLOTZ, U.Clinical pharmacokinetics. 1985, Vol 10, Num 4, pp 285-302, issn 0312-5963Article
CLEARANCE OF DIAZEPAM CAN BE IMPAIRED BY ITS MAJOR METABOLITE DESMETHYLDIAZEPAMKLOTZ U; REIMANN I.1981; EUR. J. CLIN. PHARMACOL.; ISSN 0031-6970; DEU; DA. 1981; VOL. 21; NO 2; PP. 161-163; BIBL. 16 REF.Article
RAT DIAPHRAGM CYCLIC NUCLEOTIDE-PHOSPHODIESTERASE: INFLUENCE OF DRUGS AFFECTING SKELETAL MUSCLE CONTRACTILITY = LA PHOSPHODIESTERASE DES NUCLEOTIDES CYCLIQUES DU DIAPHRAGME DU RAT: INFLUENCE DES MEDICAMENTS AFFECTANT LA CONTRACTILITE DU MUSCLE DU SQUELETTEKLOTZ U; VAPAATALO H.1974; ARCH. (NAUNYN-SCHMIEDEBERG'S) PHARMACOL.; GERM.; DA. 1974; VOL. 284; NO 4; PP. 373-382; BIBL. 1P.1/2Article
Wirkungen und Nebenwirkungen der Benzodiazepine = Actions et effets secondaires des benzodiazépines = Effects and side effects of benzodiazepinesKLOTZ, U.Anästhesie, Intensivtherapie, Notfallmedizin. 1988, Vol 23, Num 3, pp 122-126, issn 0174-1837Article
THE PHARMACOKINETICS AND TISSUE DISTRIBUTION OF THE NEW ANTIARRHYTHMIC AGENT LORCAINIDE (R 15889) IN RATSKLOTZ U; GOLBS E.1980; ARZNEIMITTEL-FORSCH.; DEU; DA. 1980; VOL. 30; NO 4; PP. 619-621; ABS. GER; BIBL. 11 REF.Article
HIGH-PERFORMANCE LIQUID CHROMATOGRAPHIC DETERMINATION OF AMINOSALICYLATE, SULFAPYRIDINE AND THEIR METABOLITES. ITS APPLICATION FOR PHARMACOKINETIC STUDIES WITH SALICYLAZOSULFAPYRIDINE IN MANFISCHER C; KLOTZ U.1979; J. CHROMATOGR.; NLD; DA. 1979; VOL. 162; NO 2; PP. 237-243; BIBL. 12 REF.Article
The Pharmacological Profile and Clinical Use of Mesalazine (5-Aminosalicylic Acid)KLOTZ, U.Arzneimittel-Forschung. 2012, Vol 62, Num 2, pp 53-58, issn 0004-4172, 6 p.Article
The role of aminosalicylates at the beginning of the new millennium in the treatment of chronic inflammatory bowel diseaseKLOTZ, U.European journal of clinical pharmacology. 2000, Vol 56, Num 5, pp 353-362, issn 0031-6970Article